1. Germany Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Dermapharm Holding SE

Dermapharm Holding SE

52D0.F
Dermapharm Holding SEundefined flagFrankfurt Stock Exchange
0.22
EUR
+0.00
- -
145.29MMarket Cap
Dermapharm Holding SE
52D0.F
(Frankfurt Stock Exchange)

Recent

price

0.22

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
TTM
FRC
- -
0.05
0.06
0.08
0.07
0.06
Revenue per Share
-0.15
-0.28
-0.04
- -
-0.08
-0.06
Basic EPS, GAAP
-0.16
-0.16
-0.04
- -
-0.03
-0.02
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
0.68
1.2
0.21
0.14
0.07
0.06
Book Value per Share
0.6
-0.05
0.08
0.06
0.02
0.01
Tangible Book Value per Share
34
128
438
649
662
664
Basic Weighted Avg Shares
- -
6
28
55
46
37
Sales/Revenue/Turnover
- -
-627.43
-60.53
-8.75
-53.83
-74.74
Operating Margin (%)
- -
5
11
9
8
8
Depreciation Expense
-5
-36
-17
-1
-51
-42
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
-549.1
-61.88
-2.26
-111.03
-113.23
Profit Margin (%)
21
12
26
34
13
8
Working Capital
- -
- -
- -
- -
2
1
LT Debt
25
165
104
102
60
53
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-40.18
-14.34
-1.39
-77.23
-72.94
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
2
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
665
665
666
Market Capitalization
226
195
208

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2,350
1,624
1,172
Cash, Cash Equivalents & STI
32
29
27
Accounts Receivable, Net
- -
- -
- -
Inventories
10
7
3
Total Current Liabilities
2,324
1,610
1,163
Payables & Accruals
11
11
11
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-41.82%
Free Cash Flow
- -
- -
671.16%
Net Income, GAAP
- -
- -
4,012.11%
Sales/Revenue/Turnover
- -
- -
-16.29%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
19
12
7
20
55
2025
16
10
11
9
46
2026
7
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
-0.01
- -
- -
2025
-0.02
-0.01
-0.02
- -
-0.08
2026
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Crescita Therapeutics Inc. (CTX.TO)
Shandong Xinhua Pharmaceutical Company Limited (0719.HK)
Gold River Productions, Inc. (GRPS)
Medico Remedies Limited (MEDICO.BO)
Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
Cannabis Bioscience International Holdings, Inc. (CBIH)
Business
WonderFi Technologies Inc. is a technology company primarily engaged in the development and provision of decentralized finance (DeFi) solutions and blockchain infrastructure. The company offers a range of products and services including cryptocurrency trading platforms; decentralized finance protocol development; blockchain-enabled financial services; digital wallet solutions; and related software tools for secure digital asset management. WonderFi serves individual retail investors as well as institutional clients seeking access to DeFi markets primarily in North America, with operations headquartered in Toronto, Canada. Founded in 2020, the company focuses on driving adoption of decentralized finance through user-friendly platforms and technology integration. Recently, WonderFi has made significant strategic moves to expand its offerings and market reach. In the past one to two years, it has entered key partnerships and strategic alliances to enhance its technological capabilities and product portfolio. It has also completed funding rounds to support product development and market expansion initiatives. Notably, the company has launched new decentralized finance products and upgraded its digital services, positioning itself as a comprehensive player in the blockchain finance ecosystem. These operational developments signal a strategic shift toward broader DeFi adoption and increased market penetration. WonderFi continues to refine its platform offerings to encompass innovative blockchain financial solutions, reflecting an ongoing evolution in its business scope and technology application.